Extra vaccine dose tested to protect vulnerable kidney patients from shingles
NCT ID NCT04128189
Summary
This study is testing whether an extra dose of the shingles vaccine (Shingrix) provides better protection for people with kidney failure who receive a transplant. Researchers want to see how well the vaccine works and how safe it is in this group, who are at higher risk for shingles. The study will compare people who get a third dose after transplant to those who don't, to see if the extra dose improves their immune response.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KIDNEY FAILURE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Baylor College of Medicine
RECRUITINGHouston, Texas, 77030, United States
Contact Email: •••••@•••••
Contact
-
Brigham and Women's Hospital
RECRUITINGBoston, Massachusetts, 02115, United States
Contact Email: •••••@•••••
Contact
-
Emory University
RECRUITINGAtlanta, Georgia, 30322, United States
Contact Email: •••••@•••••
Contact
-
University of Colorado Anschutz
RECRUITINGAurora, Colorado, 80045, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.